Corbus Pharmaceuticals says a Phase 3 clinical trial of anabasum for diffuse cutaneous scleroderma will start in the fourth…
read moreToday, the 37-year-old, who became quadriplegic after a 2015 bike accident and can’t move from the neck down, was…
read moreeSight 3 is a pair of breakthrough, electronic glasses that let the visually impaired actually see. Read more >>
read morePixability (www.pixability.com), the leading provider of software and insights for video advertising on YouTube and Connected TV (CTV), today…
read moreDon Straus explains how his firm First Light Biosciences is pioneering a way of better diagnosing infections in order…
read moreOn Wednesday, the Wolf Administration plans to highlight what it calls in a news advisory a “promising new drug…
read moreIn advance of CES, I was alerted to two products in this category that I wanted to check out….
read moreDetraPel aims for us to wear and love our belongings longer by protecting fabrics against liquid damage such as…
read moreThe Dartmouth General Hospital Foundation is raising money for a COVID-19 Response Fund to support the needs of staff…
read moreShares of Carbonite Inc. (CARB) broke into a new 52-week high yesterday, hitting a peak of $19.63. Shares closed…
read more